首页 | 本学科首页   官方微博 | 高级检索  
     

苦参素对实验性自身免疫性脑脊髓炎大鼠CCL2,CCR2mRNA表达的影响
引用本文:潘清霞,吕莹,张晓坚,赵晓玉,吕鹏,张光先,朱琳. 苦参素对实验性自身免疫性脑脊髓炎大鼠CCL2,CCR2mRNA表达的影响[J]. 中国实验方剂学杂志, 2016, 22(5): 131-135
作者姓名:潘清霞  吕莹  张晓坚  赵晓玉  吕鹏  张光先  朱琳
作者单位:郑州大学 第一附属医院, 郑州 450000,郑州大学, 郑州 450000,郑州大学 第一附属医院, 郑州 450000,郑州大学 第一附属医院, 郑州 450000,郑州大学 第一附属医院, 郑州 450000,托马斯杰弗逊大学, 美国 费城,郑州大学 第一附属医院, 郑州 450000
基金项目:河南省郑州市科技局项目(112PPTSF317-11)
摘    要:目的:观察目前国际上公认的人类多发性硬化(MS)的理想动物模型-实验性自身免疫性脑脊髓炎(EAE)大鼠模型脊髓中单核细胞趋化蛋白2(CCL2),单核细胞趋化蛋白受体2(CCR2)mRNA表达,探讨苦参素对EAE大鼠的保护作用,为临床应用提供依据。方法:将50只雌性Wistar大鼠随机分5组,分别为正常组,模型组,苦参素低、高剂量组(150,250 mg·kg~(-1)),地塞米松组(1 mg·kg~(-1)),每组10只,自免疫当天起连续给药16 d,同期正常组、模型组ip等量生理盐水,观察记录大鼠的临床症状,并检查组织病理学变化,采用RT-PCR法检测脊髓中CCL2,CCR2 mRNA的表达。结果:与模型组比较,苦参素有效延迟EAE大鼠的发病时间,明显降低临床神经功能学评分(P0.01),改善EAE大鼠中枢神经系统炎症浸润(P0.01)和髓鞘脱失(P0.01)程度,下调脊髓中CCL2,CCR2 mRNA的表达(P0.01,P0.01)。结论:苦参素对EAE大鼠有防治作用,其作用机制可能与下调大鼠脊髓中CCL2,CCR2 mRNA的表达有关。

关 键 词:苦参素  多发性硬化  实验性自身免疫性脑脊髓炎  单核细胞趋化蛋白2  单核细胞趋化蛋白受体2
收稿时间:2015-05-13

Effect of Matrine on Expression of CCL2,CCR2 mRNA in Experimental Autoimmune Encephalomyetic Rats
PAN Qing-xi,LYU Ying,ZHANG Xiao-jian,ZHAO Xiao-yu,LYU Peng,ZHANG Guang-xian and ZHU Lin. Effect of Matrine on Expression of CCL2,CCR2 mRNA in Experimental Autoimmune Encephalomyetic Rats[J]. China Journal of Experimental Traditional Medical Formulae, 2016, 22(5): 131-135
Authors:PAN Qing-xi  LYU Ying  ZHANG Xiao-jian  ZHAO Xiao-yu  LYU Peng  ZHANG Guang-xian  ZHU Lin
Affiliation:The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China,Zhengzhou University, Zhengzhou 450000, China,The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China,The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China,The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China,Thomas Jefferson University, Philadelphia and The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
Abstract:Objective: To observe the effect of matrine (MAT) on the expression of chemokine ligand-2 (CCL2) and its receptor CCR2 mRNA in experimental autoimmune encephalomyetic (EAE) rats in the internationally accepted models of multipe sclerosis (MS), investigate the possible mechanism of MAT preventive treatment for EAE rats and provide clinical evidence. Method: The 50 Wistar female rats were divided into five groups randomly (n=10 each group):normal group, model group, MAT low-dose group (150 mg · kg-1), MAT high-dose group (250 mg · kg-1), and dexamethasone group (1 mg · kg-1). The MAT and dexamethasone were respectively injected intraperitoneally (ip) daily from day 0 post-immunization till to 17. At the same time, The model and normal group received the same amount of normal saline. The clinical symptoms were observed and recorded and the histopathological changes were detected. The expression levels of CCL2,CCR2 mRNA were detected using RT-PCR techniques. Result: Compared with model group, MAT obviously delayed the disease onset and ameliorated clinical symptoms of EAE (P<0.01), improved inflammatory infiltration (P<0.01) and demyelination (P<0.01) in central nervous system of EAE rats, and reduced the expression levels of CCL2/CCR2 mRNA in spinal cord (P<0.01, P<0.01). Conclusion: Matrine could prevent and treat EAE rats and the mechanism may be associated with reducing the expression of CCL2/CCR2 mRNA in spinal cord of EAE rats.
Keywords:matrine  multipe sclerosis  experimental autoimmune encephalomyelitis  chemokine ligand-2  chemokine ligand receptor-2
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号